yte

Filed a patent for "bicyclic dgk inhibitors" on Thu, August 24, 2023

Filed a patent for "salts of an fgfr inhibitor" on Thu, February 13, 2025

Filed a patent for "methods of treating chronic graft-versus-host disease using an anti-colony stimulating factor 1 receptor antibody" on Sun, July 23, 2023

Filed a patent for "methods of treating chronic graft-versus-host disease using an anti-colony stimulating factor 1 receptor antibody" on Fri, December 8, 2023

Filed a patent for "salts of a pim kinase inhibitor" on Thu, January 16, 2025

Filed a patent for "formulations of an axl/mer inhibitor" on Thu, December 26, 2024

Filed a patent for "combinations and uses thereof" on Thu, December 26, 2024

Filed a patent for "combination therapy of anti-pd-1 active agent, anti-tim-3 active agent, and anti-lag-3 active agent for treating cancer" on Wed, March 8, 2023

Filed a patent for "bicyclic amines as cdk2 inhibitors" on Fri, June 9, 2023

Filed a patent for "topical ruxolitinib foam for treating alopecia" on Sun, May 21, 2023

Filed a patent for "aminopyrazine diol compounds as pi3k-y inhibitors" on Thu, December 5, 2024

Filed a patent for "use of jak1 inhibitors for the treatment of cutaneous lupus erythematosus and lichen planus (lp)" on Thu, November 28, 2024

Filed a patent for "pyrrolidine kras inhibitors" on Tue, April 18, 2023

Filed a patent for "pyrrolidine kras inhibitors" on Wed, September 6, 2023

Filed a patent for "cyclic urea kras inhibitors" on Tue, April 18, 2023

Filed a patent for "2-azabicyclo[2.2.1]heptane kras inhibitors" on Tue, April 18, 2023

Filed a patent for "macrocyclic kinase inhibitors" on Fri, May 5, 2023

Filed a patent for "2-azabicyclo[2.2.1]heptane kras inhibitors" on Wed, September 6, 2023

Filed a patent for "pyrazolopyridine compounds and uses thereof" on Thu, November 21, 2024

Filed a patent for "combinations and uses thereof" on Thu, November 7, 2024

Filed a patent for "2-azabicyclo[2.2.1]heptane kras inhibitors" on Fri, February 23, 2024

Filed a patent for "jak1 pathway inhibitors for the treatment of vitiligo" on Thu, October 31, 2024

Filed a patent for "fused pyrazine derivatives as a2a / a2b inhibitors" on Thu, October 31, 2024

Filed a patent for "2-azabicyclo[2.2.1]heptane kras inhibitors" on Thu, November 7, 2024

Filed a patent for "macrocyclic kinase inhibitors" on Thu, November 14, 2024